Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imagingtranslating…

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has...

Factuality

73/100

Political Bias

Lean Left

Ownership

PR Press Ltd

Country

Unknown

Region

Asia

Keywords#Telix#FDA#BiPASS#BiPASS Pre-Biopsy#BiPASS Pre-Biopsy Prostate

Read Original ↗